208 related articles for article (PubMed ID: 19377765)
21. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE
Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150
[No Abstract] [Full Text] [Related]
22. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
Micantonio T; Fargnoli MC; Peris K
Arch Dermatol; 2006 Apr; 142(4):530-1. PubMed ID: 16618884
[No Abstract] [Full Text] [Related]
23. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
Powell AM; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
[TBL] [Abstract][Full Text] [Related]
24. Topical imiquimod therapy for lentigo maligna.
Mahoney MH; Joseph MG; Temple C
Ann Plast Surg; 2008 Oct; 61(4):419-24. PubMed ID: 18812714
[TBL] [Abstract][Full Text] [Related]
25. Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
Kai AC; Richards T; Coleman A; Mallipeddi R; Barlow R; Craythorne EE
Br J Dermatol; 2016 Jan; 174(1):165-8. PubMed ID: 26595446
[TBL] [Abstract][Full Text] [Related]
26. Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'.
Guitera P; Waddell A; Paton E; Fogarty GB; Hong A; Scolyer RA; Stretch JR; O'Donnell BA; Pellacani G
Australas J Dermatol; 2022 May; 63(2):e198-e199. PubMed ID: 35107826
[No Abstract] [Full Text] [Related]
27. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
[TBL] [Abstract][Full Text] [Related]
28. Treatment of lentigo maligna with topical 1% cidofovir.
Calista D
Br J Dermatol; 2007 Aug; 157(2):421-3. PubMed ID: 17596162
[No Abstract] [Full Text] [Related]
29. [Imiquimod in the treatment of lentigo maligna].
Nagore E; Botella-Estrada R
Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
[No Abstract] [Full Text] [Related]
30. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
Bartenjev MS; Isaković-Vidović S; Bartenjev I
Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
[TBL] [Abstract][Full Text] [Related]
31. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
[TBL] [Abstract][Full Text] [Related]
32. Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod.
Rovesti M; Zucchi A; Feliciani C; Satolli F
An Bras Dermatol; 2021; 96(5):565-568. PubMed ID: 34261602
[TBL] [Abstract][Full Text] [Related]
33. Imiquimod in the treatment of lentigo maligna.
Rajpar SF; Marsden JR
Br J Dermatol; 2006 Oct; 155(4):653-6. PubMed ID: 16965411
[TBL] [Abstract][Full Text] [Related]
34. In vivo reflectance confocal microscopy to monitor the response of lentigo maligna to imiquimod.
Alarcon I; Carrera C; Alos L; Palou J; Malvehy J; Puig S
J Am Acad Dermatol; 2014 Jul; 71(1):49-55. PubMed ID: 24725478
[TBL] [Abstract][Full Text] [Related]
35. Image in clinical medicine. Lentigo maligna.
Noel B; Kunzle N
N Engl J Med; 2005 Nov; 353(20):2176. PubMed ID: 16291987
[No Abstract] [Full Text] [Related]
36. Amelanotic lentigo maligna managed with topical imiquimod.
Lapresta A; García-Almagro D; Sejas AG
J Dermatol; 2012 May; 39(5):503-5. PubMed ID: 21973079
[No Abstract] [Full Text] [Related]
37. Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna.
Muir J; McCormack C; De'Ambrosis B; Brown H; Kennedy D; Louie B; Smithers BM
Australas J Dermatol; 2022 May; 63(2):e197-e198. PubMed ID: 35262178
[No Abstract] [Full Text] [Related]
38. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs T; van Doorn R; Kirtschig G
Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
[No Abstract] [Full Text] [Related]
39. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
[No Abstract] [Full Text] [Related]
40. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
Lallas A; Moscarella E; Kittler H; Longo C; Thomas L; Zalaudek I; Kyrgidis A; Manoli SM; di Meo N; Papageorgiou C; Apalla Z; Argenziano G
Br J Dermatol; 2021 Sep; 185(3):675-677. PubMed ID: 33894006
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]